GeneFerm Biotechnology Co Ltd (1796) — Cash Flow Quality Index
GeneFerm Biotechnology Co Ltd (1796) has a Cash Flow Quality Index of 1.61x as of June 2025. Operating cash flow of NT$1.45 Million exceeds net income of NT$898.00K, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of GeneFerm Biotechnology Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GeneFerm Biotechnology Co Ltd Cash Flow Quality Index (2017–2023)
Historical Cash Flow Quality Index for GeneFerm Biotechnology Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see GeneFerm Biotechnology Co Ltd cash flow conversion.
Annual Cash Flow Quality Index for GeneFerm Biotechnology Co Ltd (2017–2023)
Year-by-year earnings quality comparison for GeneFerm Biotechnology Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.24x | NT$190.31 Million | NT$153.43 Million | ▲ +11.7% |
| 2022 | 1.11x | NT$122.43 Million | NT$110.21 Million | ▼ -30.3% |
| 2021 | 1.59x | NT$112.23 Million | NT$70.40 Million | ▼ -80.9% |
| 2020 | 8.33x | NT$56.42 Million | NT$6.77 Million | ▲ +104.0% |
| 2018 | 4.08x | NT$42.14 Million | NT$10.31 Million | ▲ +88.8% |
| 2017 | 2.16x | NT$61.08 Million | NT$28.23 Million | — |